☰

Ramez Kouzy - Publications

Affiliations: 
MD Anderson Cancer Center, Houston, TX, United States 
Tree Info Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Sherry AD, Hahn AW, McCaw ZR, Abi Jaoude J, Kouzy R, Lin TA, Minsky B, Fuller CD, Meirson T, Msaouel P, Ludmir EB. Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020. Jama Network Open. 7: e243379. PMID 38546648 DOI: 10.1001/jamanetworkopen.2024.3379  0.525
2024 Hsu EJ, Lin TA, Dabush DR, McCaw Z, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Noticewala S, Yang Y, Sherry AD, Fuller CD, Thomas CR, et al. Association of differential censoring with survival and suboptimal control arms among oncology clinical trials. Journal of the National Cancer Institute. PMID 38331394 DOI: 10.1093/jnci/djae028  0.549
2024 Ludmir EB, Hoffman KE, Jhingran A, Kouzy R, Ip MP, Sturdevant L, Ning MS, Minsky BD, McAleer MF, Chronowski GM, Arzu IY, Reed VK, Garg AK, Roberts T, Eastwick GA, et al. Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network. Practical Radiation Oncology. PMID 38176466 DOI: 10.1016/j.prro.2023.12.007  0.527
2023 Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, et al. Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. European Journal of Cancer (Oxford, England : 1990). 194: 113357. PMID 37827064 DOI: 10.1016/j.ejca.2023.113357  0.696
2023 Corrigan KL, Rooney MK, Kouzy R, Manzar G, Thomas CR, Ludmir EB. Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions. Seminars in Radiation Oncology. 33: 367-373. PMID 37684066 DOI: 10.1016/j.semradonc.2023.06.002  0.611
2023 Sherry AD, Corrigan KL, Kouzy R, Jaoude JA, Yang Y, Patel RR, Totten DJ, Newman NB, Das P, Taniguchi C, Minsky B, Snyder RA, Fuller CD, Ludmir E. Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer. PMID 37382235 DOI: 10.1002/cncr.34929  0.733
2023 Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR, et al. Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. Jama Network Open. 6: e2313819. PMID 37195664 DOI: 10.1001/jamanetworkopen.2023.13819  0.697
2023 Elnaggar JH, Huynh VO, Lin D, Hillman RT, Abana CO, El Alam MB, Tomasic KC, Karpinets TV, Kouzy R, Phan JL, Wargo J, Holliday EB, Das P, Mezzari MP, Ajami NJ, et al. HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Frontiers in Immunology. 14: 1051431. PMID 37063829 DOI: 10.3389/fimmu.2023.1051431  0.7
2022 Corrigan KL, Kouzy R, Jaoude JA, Patel RR, Layman RM, Giordano SH, Woodward WA, Smith BD, Shaitelman SF, Ludmir EB. Inclusion of premenopausal women in breast cancer clinical trials. Breast (Edinburgh, Scotland). 66: 204-207. PMID 36327626 DOI: 10.1016/j.breast.2022.10.013  0.607
2022 Lin D, Alam MBE, Jaoude JA, Kouzy R, Phan JL, Elnaggar JH, Resendiz B, Medrano AYD, Lynn EJ, Nguyen ND, Noticewala SS, Mathew GG, Holliday EB, Minsky BD, Das P, et al. Microbiome Dynamics During Chemoradiotherapy for Anal Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 35513187 DOI: 10.1016/j.ijrobp.2022.04.037  0.683
2022 Patel RR, Parisi R, Verma V, Kouzy R, Abi Jaoude J, Lin TA, Fuller CD, VanderWalde NA, Jagsi R, Smith BD, Guadagnolo BA, Thomas CR, Ludmir EB. Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers. 14. PMID 35205795 DOI: 10.3390/cancers14041048  0.624
2022 Colbert LE, Alam MBE, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, et al. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16 Cancers. Cancer Immunology Research. PMID 35045973 DOI: 10.1158/2326-6066.CIR-21-0119  0.663
2021 Abi Jaoude J, Thunshelle CP, Kouzy R, Nguyen ND, Lin D, Prakash L, Bumanlag IM, Noticewala SS, Niedzielski JS, Beddar S, Ludmir EB, Holliday EB, Das P, Minsky BD, Herman JM, et al. Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Advances in Radiation Oncology. 6: 100763. PMID 34934858 DOI: 10.1016/j.adro.2021.100763  0.67
2021 Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, et al. The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 34838891 DOI: 10.1016/j.radonc.2021.11.018  0.711
2021 Abi Jaoude J, Kouzy R, Rooney M, Thompson P, Patel R, Turner MC, Ghabach M, Fuller CD, Minsky BD, Taniguchi CM, Ludmir EB. Impact factor and citation metrics in phase III cancer trials. Oncotarget. 12: 1780-1786. PMID 34504650 DOI: 10.18632/oncotarget.28044  0.714
2021 Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Food and Drug Administration approvals in phase 3 Cancer clinical trials. Bmc Cancer. 21: 695. PMID 34118915 DOI: 10.1186/s12885-021-08457-5  0.685
2021 Lin D, Moningi S, Abi Jaoude J, Singh BS, Cazacu IM, Kouzy R, Nogueras Gonzalez GM, Angsuwatcharakon P, Herman JM, Bhutani MS, Taniguchi CM. Development of an Objective Scoring System for Endoscopic Assessment of Radiation-Induced Upper Gastrointestinal Toxicity. Cancers. 13. PMID 33946696 DOI: 10.3390/cancers13092136  0.563
2021 Moningi S, Abi Jaoude J, Kouzy R, Lin D, Nguyen ND, Garcia Garcia CJ, Phan JL, Avila S, Smani D, Cazacu IM, Singh BS, Smith GL, Holliday EB, Koay EJ, Das P, et al. Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Advances in Radiation Oncology. 6: 100621. PMID 33912734 DOI: 10.1016/j.adro.2020.11.006  0.597
2021 El Alam MB, Sims TT, Kouzy R, Biegert GWG, Jaoude JABI, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, et al. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. Plos One. 16: e0247905. PMID 33662003 DOI: 10.1371/journal.pone.0247905  0.614
2020 Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, et al. Performance Status Restriction in Phase III Cancer Clinical Trials. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 1322-1326. PMID 33022640 DOI: 10.1200/Jco.2020.38.15_Suppl.2059  0.739
2020 Abi Jaoude J, Kouzy R, El Alam MB, Subbiah V, Taniguchi CM, Ludmir EB, Lin TA. Exclusion of Older Adults in COVID-19 Clinical Trials. Mayo Clinic Proceedings. 95: 2293-2294. PMID 33012364 DOI: 10.1016/j.mayocp.2020.08.018  0.643
2020 Kouzy R, Abi Jaoude J, Minsky BD, Das P, Koong AC, Subbiah IM, Ludmir EB, Taniguchi CM. Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades. Bmj Supportive & Palliative Care. PMID 32943466 DOI: 10.1136/Bmjspcare-2020-002538  0.747
2020 Kouzy R, Abi Jaoude J, Lin D, Nguyen ND, El Alam MB, Ludmir EB, Taniguchi CM. Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. Cancers. 12. PMID 32887363 DOI: 10.3390/Cancers12092487  0.731
2020 Kouzy R, Abi Jaoude J, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Fuller CD, Minsky BD, Rödel C, Taniguchi CM, Ludmir EB. Professional Medical Writer Assistance in Oncology Clinical Trials. The Oncologist. PMID 32885898 DOI: 10.1634/Theoncologist.2020-0406  0.693
2020 Kouzy R, Abi Jaoude J, Yue J, Maldonado JA, Taniguchi CM, Ludmir EB, Colbert LE. Applying to Radiation Oncology Amid a Pandemic. Advances in Radiation Oncology. 5: 777-779. PMID 32775792 DOI: 10.1016/J.Adro.2020.06.017  0.71
2020 Kouzy R, Abi Jaoude J, Garcia Garcia CJ, El Alam MB, Taniguchi CM, Ludmir EB. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. Jama Network Open. 3: e2015100. PMID 32658285 DOI: 10.1001/jamanetworkopen.2020.15100  0.673
2020 Abi Jaoude J, Kouzy R, Minsky BD, Fuller CD, Yuan Y, Do KA, Taniguchi CM, Ludmir EB. Sponsor-Involved Statistical Analyses in Phase III Cancer Clinical Trials. International Journal of Cancer. PMID 32621758 DOI: 10.1002/Ijc.33180  0.748
2020 Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp AH, Colbert LE, Taniguchi CM. Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation. Jco Oncology Practice. OP2000122. PMID 32609585 DOI: 10.1200/Op.20.00122  0.729
2020 Lin D, Kouzy R, Abi Jaoude J, Noticewala SS, Delgado Medrano AY, Klopp AH, Taniguchi CM, Colbert LE. Microbiome factors in HPV-driven carcinogenesis and cancers. Plos Pathogens. 16: e1008524. PMID 32497113 DOI: 10.1371/Journal.Ppat.1008524  0.703
2020 Abi Jaoude J, Kouzy R, Nguyen ND, Lin D, Noticewala SS, Ludmir EB, Taniguchi CM. Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. Current Problems in Cancer. 100607. PMID 32471736 DOI: 10.1016/J.Currproblcancer.2020.100607  0.678
2020 Colbert LE, Kouzy R, Abi Jaoude J, Ludmir EB, Taniguchi CM. Cancer Research after COVID-19: Where Do We Go from Here? Cancer Cell. 37: 637-638. PMID 32396859 DOI: 10.1016/J.Ccell.2020.04.003  0.751
2020 Noticewala SS, Lin D, Kouzy R, Maitra A, Colbert LE, Taniguchi CM. Pancreatic cancer intratumoral microbiome and characteristics within paired patient samples. Journal of Clinical Oncology. 38: 744-744. DOI: 10.1200/Jco.2020.38.4_Suppl.744  0.713
2020 Kouzy R, Lin D, Noticewala SS, Colbert LE, Taniguchi CM. Enhanced microbial diversity and chemoradiation response in HPV+ anal cancer. Journal of Clinical Oncology. 38: 4-4. DOI: 10.1200/Jco.2020.38.4_Suppl.4  0.713
2020 Jaoude JA, Kouzy R, Mainwaring W, Lin T, Miller AB, Jethanandani A, Espinoza AF, Taniguchi CM, Ludmir EB. Professional medical writing assistance in oncology clinical trials. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E14088  0.658
2020 Jaoude JA, Kouzy R, Mainwaring W, Lin T, Miller AB, Jethanandani A, Espinoza AF, Ludmir EB, Taniguchi CM. The landscape of gastrointestinal oncologic phase III clinical trials in the last two decades. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E14087  0.75
2020 Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp A, Colbert LE, Taniguchi CM. Patient-reported gastrointestinal outcomes in patients with anal cancer. Journal of Clinical Oncology. 38: 4055-4055. DOI: 10.1200/Jco.2020.38.15_Suppl.4055  0.722
2020 Kouzy R, Jaoude JA, El Alam M, Mainwaring W, Lin T, Miller A, Jethanandani A, Espinoza A, Ludmir E, Taniguchi C. Phase III Radiation Oncology Clinical Trials: A Snapshot of the Last Two Decades International Journal of Radiation Oncology*Biology*Physics. 108: e788-e789. DOI: 10.1016/j.ijrobp.2020.07.259  0.694
2020 Thunshelle C, Kouzy R, Jaoude JA, Chowdhury T, Zaid M, Mathew R, Prakash L, Katz M, Minsky B, Holliday E, Das P, Smith G, Herman J, Koong A, Taniguchi C, et al. Patient-Reported Outcomes in Prospective Cohort of Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Undergoing Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 108: e628. DOI: 10.1016/j.ijrobp.2020.07.1897  0.587
2020 Thunshelle C, Zaid M, Jaoude JA, Chowdhury T, Dai A, Kouzy R, Mathew R, Prakash L, Katz M, Varadhachary G, Tamm E, Minsky B, Holliday E, Das P, Smith G, et al. Neutrophil-Lymphocyte Ratio and Tumor Interface Response as Predictors of Outcomes for Prospective Cohort of Patients with Pancreatic Ductal Adenocarcinoma International Journal of Radiation Oncology*Biology*Physics. 108: e618. DOI: 10.1016/j.ijrobp.2020.07.1873  0.498
Show low-probability matches.